Figure 3.

CircRNA signature to predict recurrence in and progression-free survival of patients with non-functioning pituitary adenomas. Kaplan-Meier survival curves of patients sorted into high- and low-risk groups using the circRNA signature in the (A) training and (B) test datasets. P-values were calculated using a log-rank test. The predictive power of the circRNA signature compared with that of age based on ROC curves in (C) training and (D) test datasets. CircRNA, circular RNA; ROC, receiver operating curves; AUROC, area under the ROC; CI, confidence interval.